355 related articles for article (PubMed ID: 29132385)
1. Aptamer selection and applications for breast cancer diagnostics and therapy.
Liu M; Yu X; Chen Z; Yang T; Yang D; Liu Q; Du K; Li B; Wang Z; Li S; Deng Y; He N
J Nanobiotechnology; 2017 Nov; 15(1):81. PubMed ID: 29132385
[TBL] [Abstract][Full Text] [Related]
2. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics.
Gholikhani T; Kumar S; Valizadeh H; Mahdinloo S; Adibkia K; Zakeri-Milani P; Barzegar-Jalali M; Jimenez B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430951
[TBL] [Abstract][Full Text] [Related]
3. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
4. Aptamers used for biosensors and targeted therapy.
Ning Y; Hu J; Lu F
Biomed Pharmacother; 2020 Dec; 132():110902. PubMed ID: 33096353
[TBL] [Abstract][Full Text] [Related]
5. Generating aptamers by cell-SELEX for applications in molecular medicine.
Ye M; Hu J; Peng M; Liu J; Liu J; Liu H; Zhao X; Tan W
Int J Mol Sci; 2012; 13(3):3341-3353. PubMed ID: 22489154
[TBL] [Abstract][Full Text] [Related]
6. Aptamers in hematological malignancies and their potential therapeutic implications.
Ouyang W; Yu Z; Zhao X; Lu S; Wang Z
Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356
[TBL] [Abstract][Full Text] [Related]
7. Selection of DNA aptamers for extra cellular domain of human epidermal growth factor receptor 2 to detect HER2 positive carcinomas.
Sett A; Borthakur BB; Bora U
Clin Transl Oncol; 2017 Aug; 19(8):976-988. PubMed ID: 28224267
[TBL] [Abstract][Full Text] [Related]
8. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
9. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
[TBL] [Abstract][Full Text] [Related]
10. Novel insights into the role of aptamers in the fight against cancer.
Maimaitiyiming Y; Hong F; Yang C; Naranmandura H
J Cancer Res Clin Oncol; 2019 Apr; 145(4):797-810. PubMed ID: 30830295
[TBL] [Abstract][Full Text] [Related]
11. Oligonucleotide aptamers for glioma targeting: an update.
Camorani S; Cerchia L
Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
[TBL] [Abstract][Full Text] [Related]
12. Chimeric aptamers in cancer cell-targeted drug delivery.
Kanwar JR; Roy K; Kanwar RK
Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-drug conjugation for targeted tumor cell therapy.
Donovan MJ; Meng L; Chen T; Zhang Y; Sefah K; Tan W
Methods Mol Biol; 2011; 764():141-52. PubMed ID: 21748638
[TBL] [Abstract][Full Text] [Related]
14. Aptamers in targeted nanotherapy.
Mathew A; Maekawa T; Sakthikumar D
Curr Top Med Chem; 2015; 15(12):1102-14. PubMed ID: 25866269
[TBL] [Abstract][Full Text] [Related]
15. Trends in aptamer selection methods and applications.
Yüce M; Ullah N; Budak H
Analyst; 2015 Aug; 140(16):5379-99. PubMed ID: 26114391
[TBL] [Abstract][Full Text] [Related]
16. Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer.
Subramanian N; Raghunathan V; Kanwar JR; Kanwar RK; Elchuri SV; Khetan V; Krishnakumar S
Mol Vis; 2012; 18():2783-95. PubMed ID: 23213278
[TBL] [Abstract][Full Text] [Related]
17. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
Zhong Y; Zhao J; Li J; Liao X; Chen F
Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
[TBL] [Abstract][Full Text] [Related]
18. In silico selection of an aptamer to estrogen receptor alpha using computational docking employing estrogen response elements as aptamer-alike molecules.
Ahirwar R; Nahar S; Aggarwal S; Ramachandran S; Maiti S; Nahar P
Sci Rep; 2016 Feb; 6():21285. PubMed ID: 26899418
[TBL] [Abstract][Full Text] [Related]
19. Aptamer Technology and Its Applications in Bone Diseases.
Liu X; Hu J; Ning Y; Xu H; Cai H; Yang A; Shi Z; Li Z
Cell Transplant; 2023; 32():9636897221144949. PubMed ID: 36591965
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
